We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

USIO:NASDAQUsio, Inc. Analysis

Data as of 2026-05-07 - not real-time

$1.31

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Usio, Inc. is trading at $1.31, which sits just above its 20‑day (1.213) and 50‑day (1.219) SMAs but remains well below the 200‑day SMA (1.390), indicating a short‑term bounce in a longer‑term downtrend. The RSI of 62 points to modest overbought pressure, while the MACD histogram is positive and the signal line is bullish, suggesting limited upside momentum. Fundamentally, the company generates $85 M in revenue with 8.2% YoY growth, yet margins are thin to negative – gross margin 23%, operating margin –5.7% and net profit margin –2.9% – and earnings per share are in the red. Cash flow is a bright spot, with operating cash flow of $1.5 M and free cash flow of $0.67 M, but the balance sheet shows a debt‑to‑equity ratio of 21.7% and total debt of $3.9 M against cash of $7.4 M. The DCF‑derived fair value of $0.59 is less than half the current price, implying the stock is **overvalued** relative to intrinsic estimates, while the market’s target price median of $5.13 suggests speculative optimism. Volatility is high at 42% over the past 30 days, and the Fear & Greed Index reads “Extreme Greed,” highlighting potential investor euphoria. With volume trending upward but market cap only $36 M, liquidity remains a concern.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • price above short‑term SMAs but below long‑term SMA
  • DCF fair value far below market price
  • high 30‑day volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • positive operating cash flow despite negative earnings
  • moderate revenue growth of 8%
  • persistent negative margins and earnings

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • potential for turnaround if margins improve
  • limited debt relative to cash reserves
  • sector exposure to regulatory changes in payment processing

Key Metrics & Analysis

Financial Health

Revenue Growth8.20%
Profit Margin-2.94%
P/E Ratio-43.7
ROE-13.55%
ROA-1.22%
Debt/Equity21.72
P/B Ratio2.0
Op. Cash Flow$1.5M
Free Cash Flow$670.6K
Industry P/E37.2

Technical Analysis

TrendBearish
RSI62.0
Support$1.14
Resistance$1.40
MA 20$1.21
MA 50$1.22
MA 200$1.39
MACDBullish
VolumeIncreasing
Fear & Greed Index90.93

Valuation

Fair Value$0.59
Target Price$5.06
Upside/Downside286.45%
GradeOvervalued
TypeBlend

Risk Assessment

Beta0.74
Volatility42.44%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.